Navigation Links
Research indicates need for effective HPV vaccine for women and men and a simple HPV screening test

A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.

Leading HPV expert Maura Gillison, M.D., Ph.D., the first to identify HPV infection as the cause of certain oral cancers and who identified multiple sex partners as the most important risk factor for these cancers, reports her latest work in the November 3, 2008, journal Clinical Cancer Research and in a Centers for Disease Control and Prevention (CDC) monograph. The CDC report on HPV-associated cancers appears on line November 3 and in the November 15, 2008, supplement edition of Cancer.

In the CDC report, believed to be the first and most comprehensive assessment of HPV-associated cancer data in the United States, investigators analyzed cancer registry data from 1998-2003 and found 25,000 cancer cases each year occurred at cancer sites associated with HPV infection. In additional analysis, Gillison and colleagues at the National Cancer Institute identified HPV infection as the underlying cause of approximately 20,000 of these cancers.

Gillison and team found approximately 20,000 cases of cancer in the United States each year are caused by HPV infection. Oral cancers are the second most common type of HPV-associated cancers and are increasing in incidence in the U.S., particularly among men. Add to that anal, penile, vaginal, and vulvar cancers that are also linked to HPV infection, and Gillison says these cancers, when combined, equal the number of cervical cancers, the most common and well known of the cancers caused by HPV.

While about one-quarter of HPV-linked cancers occur in men, vaccines are currently approved only for use in girls and young women for cervical cancer prevention. "We need to have a more comprehensive discussion of the potential impact the HPV vaccine could have on cancer rates among men and women in this country," says Gillison, associate professor of oncology. "Currently available HPV vaccines have the potential to reduce the rates of HPV-associated cancers, like oral and anal cancers, that are currently on the rise and for which there no effective or widely-applied screening programs." Gillison notes, however, that studies are needed to confirm that the vaccine effectively prevents HPV infections that lead to oral and anal cancers.

Gillison's findings were part of a project known as ABHACUS (Assessing the Burden of Human Papillomavirus-Associated Cancers). The data studied came from the CDC's National Program of Cancer Registries and the National Cancer Institute's Surveillance, Epidemiology, and End Results program. More than 80 investigators from across the country participated in the project, which addressed a variety of HPV-cancer associated issues, including racial disparity, economic impact, behavioral risk factors, and cancer mortality.

Other then prevention, early detection is held by cancer experts as the best way to control cancer. In the Clinical Cancer Research study, the first to track the disease and related oral infections over an extended period, Gillison found that simple "swish and spit" oral rinses can successfully track oral HPV infection over time. These findings open the door to a potential, non-invasive screening test to detect the disease and monitor for tumor recurrence. Head and neck cancer is the broad term for a variety of cancers of the oral cavity, including the tonsils, base of the tongue, and the side and back wall of the throat.

The study found that oral rinses successfully detected high-risk HPV infections in patients with HPV 16-positive head and neck cancers for up to five years after treatment for their cancer. Gillison says the findings indicate a high rate of persistent infection and reaffirms the connection between high-risk types of HPV and HPV-positive head and neck cancers.

In the study, the researchers used oral rinses to collect cells shed from inside the mouths of 135 head and neck cancer patients. The researchers genetically sequenced the DNA obtained from the rinses and tumor samples to identify those with HPV-positive cancers and determine the HPV type. There are approximately 120 types of HPV, but HPV 16 is one of the two most common associated with cancer.

The analysis revealed 44 patients with HPV 16-positive tumors and found that these patients were more likely to have continuing oral HPV 16 infections both before and after cancer treatment. While this study did not link the continued post-treatment infections to tumor recurrence, it was noted that patients with high-risk oral HPV infections prior to therapy, maintained high rates of infection after completing therapy. The team plans further, long-term research to determine if this continued infection leads to cancer recurrence.

In 2000, Gillison identified HPV-positive head and neck cancer as a distinct subtype of the disease and linked it to improved survival.

"There is no question of cause," says Gillison. "It has now become a question of tracking the infection over time to identify those at risk of developing cancer or cancer recurrence."


Contact: Valerie Mehl
Johns Hopkins Medical Institutions

Related medicine news :

1. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
2. New research finds markers for esophageal cancer before it develops
3. Author Royalties From Autism Book Donated to Autism Research
4. Author royalties from autism book donated to autism research
5. Stanfords Precourt Institute for Energy Efficiency awards new round of faculty research grants
6. SNM to showcase the latest research in molecular imaging and nuclear medicine
7. Urgent need for research into the best treatment for medication overuse headaches
8. Research shows aerobic exercise combined with resistance training improves glucose control in diabetics
9. New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients
10. Opt out system could solve donor organ shortage, says researcher
11. Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows
Post Your Comments:
(Date:10/13/2015)... ... ... America (MOAA) will hold its 2015 annual meeting and corresponding ... military career fair; informational seminars; a luncheon featuring keynote speaker ... Chiefs of Staff; and the Community Heroes Award Night, which ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s ... recently announced $2 billion “Ever True” capital campaign. , The investment will result ...
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater ... the local Boston chapter of Ronald McDonald House Charities® (RMHC®). This donation was made ... Sir Grout of Greater Boston since its inception. , “We believe strongly in the ...
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 ... ... growing natural beverage companies in the United States, today announced the release of ... Brew Coffee, and new Cranberry Cocktail Agua Fresca. All feature the unique flavor ...
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... Managed Care, a recent study has shown that women who successfully lose weight with ... women in the United States each year. The article notes that anywhere from 40 ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 2015  Data Science Automation (DSA), a system integration and ... branch office in the United Kingdom ... Europe . The decision to open the new ... support of customers in the medical device industry throughout the ... Manager. "We have had tremendous success over the last several ...
(Date:10/13/2015)... 13, 2015  Nanomedical Diagnostics, a biotech company ... and diagnostics, announces the completion of a Series ... Serra Ventures. --> ... easy-to-use monitoring and diagnostic platforms that empower individuals ... round will enable the company to commercially release ...
(Date:10/13/2015)... , Oct. 13, 2015 Attracting mid- to large-sized ... key to growing Baltimore into a ... today by the Maryland Technology Enterprise Institute (Mtech) . ... the pieces in place to support innovation hubs and a ... of Mtech Baltimore. "This study is important because we believe ...
Breaking Medicine Technology: